Alnylam Pharmaceuticals reported $22.44B in Market Capitalization for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Acadia Pharmaceuticals ACAD:US $ 2.67B 1.24B
Agios Pharmaceuticals AGIO:US $ 2.72B 672.75M
Alexion Pharmaceuticals ALXN:US $ 33.78B 393.15M
Alnylam Pharmaceuticals ALNY:US $ 22.44B 2.51B
Amgen AMGN:US $ 120.75B 19.29B
Arena Pharmaceuticals ARNA:US $ 3.64B 526.29M
Arrowhead Research ARWR:US $ 6.51B 2.11B
Avrobio Inc AVRO:US $ 243.58M 127.72M
Biocryst Pharmaceuticals BCRX:US $ 2.57B 239.02M
Biomarin Pharmaceutical BMRN:US $ 14.17B 1.08B
Bluebird Bio BLUE:US $ 1.29B 865.55M
Dicerna Pharmaceuticals DRNA:US $ 1.57B 1.3B
Gw Pharmaceuticals GWPH:US 6.44B 2.84B
Intercept Pharmaceuticals ICPT:US $ 493.04M 169.99M
IONIS PHARMACEUT IONS:US $ 4.73B 888.92M
Mirati Therapeutics MRTX:US $ 9.13B 823.57M
Moderna Inc MRNA:US $ 155.35B 61B
Neurocrine Biosciences NBIX:US $ 9.08B 123.68M
Novartis NVS:US 200.79B 24.12B
Ptc Therapeutics PTCT:US $ 2.63B 355.33M
Regeneron Pharmaceuticals REGN:US $ 64.73B 5.23B
Regulus Therapeutics RGLS:US $ 60.11M 810.37K
Sangamo Biosciences SGMO:US $ 1.31B 412.77M
Sanofi SNY:US 121.56B 10.5B
Sarepta Therapeutics SRPT:US $ 7.38B 1.18B
Takeda 4502:JP 5852.75B 17.24B
Ultragenyx Pharmaceutical RARE:US $ 6.12B 316.34M
Vertex Pharmaceuticals VRTX:US $ 47.06B 5.14B
Xencor XNCR:US $ 1.9B 103.31M
YTE INCY:US $ 15.19B 3.31B